BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32515734)

  • 1. The testis protein ZNF165 is a SMAD3 cofactor that coordinates oncogenic TGFβ signaling in triple-negative breast cancer.
    Gibbs ZA; Reza LC; Cheng CC; Westcott JM; McGlynn K; Whitehurst AW
    Elife; 2020 Jun; 9():. PubMed ID: 32515734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells.
    Thomas AL; Lind H; Hong A; Dokic D; Oppat K; Rosenthal E; Guo A; Thomas A; Hamden R; Jeruss JS
    Cell Cycle; 2017 Aug; 16(15):1453-1464. PubMed ID: 28678584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
    Kim S; Lee J; Jeon M; Lee JE; Nam SJ
    Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive functional characterization of cancer-testis antigens defines obligate participation in multiple hallmarks of cancer.
    Maxfield KE; Taus PJ; Corcoran K; Wooten J; Macion J; Zhou Y; Borromeo M; Kollipara RK; Yan J; Xie Y; Xie XJ; Whitehurst AW
    Nat Commun; 2015 Nov; 6():8840. PubMed ID: 26567849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
    Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PolyI:C attenuates transforming growth factor-β signaling to induce cytostasis of surrounding cells by secreted factors in triple-negative breast cancer.
    Tamura Y; Tsutsumi S; Miyazono K; Koinuma D
    Cancer Sci; 2022 Mar; 113(3):940-949. PubMed ID: 34897916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression.
    Parvani JG; Davuluri G; Wendt MK; Espinosa C; Tian M; Danielpour D; Sossey-Alaoui K; Schiemann WP
    Neoplasia; 2015 Mar; 17(3):317-28. PubMed ID: 25810016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired mammary tumor formation and metastasis by the point mutation of a Smad3 linker phosphorylation site.
    Huang CC; Huang MS; Chung HJ; Chiu SY; Yadav P; Lin Y; Liu F; Matsuura I
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3664-3671. PubMed ID: 30251686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion.
    Dai M; Al-Odaini AA; Arakelian A; Rabbani SA; Ali S; Lebrun JJ
    Breast Cancer Res; 2012 Sep; 14(5):R127. PubMed ID: 22995475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer.
    Tian J; Hachim MY; Hachim IY; Dai M; Lo C; Raffa FA; Ali S; Lebrun JJ
    Sci Rep; 2017 Jan; 7():40258. PubMed ID: 28054666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling.
    Vishnubalaji R; Alajez NM
    Sci Rep; 2021 Jul; 11(1):15410. PubMed ID: 34326372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling.
    González-González A; Muñoz-Muela E; Marchal JA; Cara FE; Molina MP; Cruz-Lozano M; Jiménez G; Verma A; Ramírez A; Qian W; Chen W; Kozielski AJ; Elemento O; Martín-Salvago MD; Luque RJ; Rosa-Garrido C; Landeira D; Quintana-Romero M; Rosato RR; García MA; Ramirez-Tortosa CL; Kim H; Rodriguez-Aguayo C; Lopez-Berestein G; Sood AK; Lorente JA; Sánchez-Rovira P; Chang JC; Granados-Principal S
    Clin Cancer Res; 2018 Nov; 24(22):5697-5709. PubMed ID: 30012564
    [No Abstract]   [Full Text] [Related]  

  • 13. CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling.
    Kang JM; Park S; Kim SJ; Hong HY; Jeong J; Kim HS; Kim SJ
    Oncogene; 2012 Dec; 31(50):5123-31. PubMed ID: 22310290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cancer gene WWOX behaves as an inhibitor of SMAD3 transcriptional activity via direct binding.
    Ferguson BW; Gao X; Zelazowski MJ; Lee J; Jeter CR; Abba MC; Aldaz CM
    BMC Cancer; 2013 Dec; 13():593. PubMed ID: 24330518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcriptional regulators TAZ and YAP direct transforming growth factor β-induced tumorigenic phenotypes in breast cancer cells.
    Hiemer SE; Szymaniak AD; Varelas X
    J Biol Chem; 2014 May; 289(19):13461-74. PubMed ID: 24648515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
    Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
    J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KAT6A Acetylation of SMAD3 Regulates Myeloid-Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple-Negative Breast Cancer.
    Yu B; Luo F; Sun B; Liu W; Shi Q; Cheng SY; Chen C; Chen G; Li Y; Feng H
    Adv Sci (Weinh); 2021 Oct; 8(20):e2100014. PubMed ID: 34392614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cancer-testis gene,
    Gu Y; Wang C; Zhu R; Yang J; Yuan W; Zhu Y; Zhou Y; Qin N; Shen H; Ma H; Wang H; Liu X; Hu Z
    Cancer Biol Med; 2021 Feb; 18(1):74-87. PubMed ID: 33628586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of CDK-mediated phosphorylation of Smad3 results in decreased oncogenesis in triple negative breast cancer cells.
    Tarasewicz E; Rivas L; Hamdan R; Dokic D; Parimi V; Bernabe BP; Thomas A; Shea LD; Jeruss JS
    Cell Cycle; 2014; 13(20):3191-201. PubMed ID: 25485498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β/activin signaling promotes CDK7 inhibitor resistance in triple-negative breast cancer cells through upregulation of multidrug transporters.
    Webb BM; Bryson BL; Williams-Medina E; Bobbitt JR; Seachrist DD; Anstine LJ; Keri RA
    J Biol Chem; 2021 Oct; 297(4):101162. PubMed ID: 34481843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.